Pharmacokinetics and Safety of Fixed‐Dose Versus Separate Enavogliflozin/Gemigliptin Combinations, and Food Effect on Enavogliflozin in Healthy Korean Subjects

Documenti analoghi

• Pharmacokinetics and Safety of Single and Multiple Doses of Molnupiravir in Healthy Male Chinese Adults: An Open‐Label, Fixed Sequence, Phase 1 Study
  di: Jixiang Zhu, et al.
  Pubblicazione: (2026)
• Genotype–Specific Safety and Pharmacokinetics of Cannabidiol in Healthy Volunteers
  di: Jumar Etkins, et al.
  Pubblicazione: (2025)
• Hemodynamic and Pharmacokinetic Interactions of TPN171 with Alcohol in Healthy Male Subjects
  di: Jie Cheng, et al.
  Pubblicazione: (2025)
• Correction to “Genotype‐Specific Safety and Pharmacokinetics of Cannabidiol in Healthy Volunteers”
  Pubblicazione: (2026)
• First‐in‐Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASP1617, a Cathepsin‐S Inhibitor, in Healthy Adult Subjects
  di: Tomoki Kojima, et al.
  Pubblicazione: (2026)